Armata Pharmaceuticals Inc Sustainability Reports
A clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for antibiotic-resistant infections.
Sector: Manufacturing
Country: United States
Exchange: NYSE American
ISIN: US04216R1023
4 reports from 2019 to 2024